Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. - Gaal,LF Van.; Rissanen,AM.; Scheen,AJ.; Ziegler,O.; Rossner,S. (Lancet, 2005)